AIC
VIR icon

Ameritas Investment Company’s Vir Biotechnology VIR Stock Holding History

Ameritas Investment Company’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13
Closed -$667 – 2035
2021
Q1 		$667 Buy
+13
New +$701 ﹤0.01% 2134
2020
Q2 		– Sell
-100
Closed -$3K – 1551
2020
Q1 		$3K Buy
+100
New +$2.69K ﹤0.01% 1521

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameritas Investment Company's VIR Position: Q2 2021 in Review

Ameritas Investment Company sold out of Vir Biotechnology (VIR) in Q2 2021, closing a stake of 13 shares — an estimated $667 sold.

Ameritas Investment Company first reported a position in VIR in Q1 2020 and held it in 2 quarters. The position peaked at $3K in Q1 2020. 165 funds tracked by Wall St. Rank hold VIR as of Q2 2021.

  • Ameritas Investment Company reported no remaining Vir Biotechnology position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 13 Vir Biotechnology shares in Q2 2021, an estimated $667.
  • Ameritas Investment Company first reported a position in Vir Biotechnology in Q1 2020 and held it in 2 quarters.
  • Ameritas Investment Company's Vir Biotechnology position peaked at $3K in Q1 2020.
  • 165 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.